These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 27868164)

  • 21. Expression of the herpes simplex virus type 2 glycoprotein D in baculovirus expression system and evaluation of its immunogenicity in guinea pigs.
    Fotouhi F; Soleimanjahi H; Roostaee MH; Dalimi Asl A
    Iran Biomed J; 2008 Apr; 12(2):59-66. PubMed ID: 18506211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Better neutralization of herpes simplex virus type 1 (HSV-1) than HSV-2 by antibody from recipients of GlaxoSmithKline HSV-2 glycoprotein D2 subunit vaccine.
    Awasthi S; Belshe RB; Friedman HM
    J Infect Dis; 2014 Aug; 210(4):571-5. PubMed ID: 24652496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intranasal immunization with a proteoliposome-derived cochleate containing recombinant gD protein confers protective immunity against genital herpes in mice.
    Del Campo J; Lindqvist M; Cuello M; Bäckström M; Cabrerra O; Persson J; Perez O; Harandi AM
    Vaccine; 2010 Feb; 28(5):1193-200. PubMed ID: 19945418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of novel immunodominant CD4+ Th1-type T-cell peptide epitopes from herpes simplex virus glycoprotein D that confer protective immunity.
    BenMohamed L; Bertrand G; McNamara CD; Gras-Masse H; Hammer J; Wechsler SL; Nesburn AB
    J Virol; 2003 Sep; 77(17):9463-73. PubMed ID: 12915561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression, purification, and immunogenic characterization of Epstein-Barr virus recombinant EBNA1 protein in Pichia pastoris.
    Wang M; Jiang S; Liu X; Wang Y
    Appl Microbiol Biotechnol; 2013 Jul; 97(14):6251-62. PubMed ID: 23685476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Eucaryotic expression and bioactivity analysis of the recombinant HSV-gD1].
    Wang Z; Li L; Guan W; Li Y
    Sheng Wu Gong Cheng Xue Bao; 2010 May; 26(5):657-63. PubMed ID: 20684311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Yeast-derived glycoprotein B-1 of herpes simplex virus (HSV) as a candidate for an HSV vaccine.
    Kino Y
    Adv Exp Med Biol; 1990; 278():183-90. PubMed ID: 1963033
    [No Abstract]   [Full Text] [Related]  

  • 28. DNA immunization confers protective immunity on mice challenged intravaginally with herpes simplex virus type 2.
    Bourne N; Milligan GN; Schleiss MR; Bernstein DI; Stanberry LR
    Vaccine; 1996 Sep; 14(13):1230-4. PubMed ID: 8961510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Novel High-Intensity Focused Ultrasound-Treated Herpes Simplex Virus 2 Vaccine Induces Long-Term Protective Immunity against Lethal Challenge in Mice.
    Xiao J; Zhou X; Luo Y; Wang S; Yang Z; Yi Y; Xiong H
    mSphere; 2020 Dec; 5(6):. PubMed ID: 33361122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant vesicular stomatitis virus vectors expressing herpes simplex virus type 2 gD elicit robust CD4+ Th1 immune responses and are protective in mouse and guinea pig models of vaginal challenge.
    Natuk RJ; Cooper D; Guo M; Calderon P; Wright KJ; Nasar F; Witko S; Pawlyk D; Lee M; DeStefano J; Tummolo D; Abramovitz AS; Gangolli S; Kalyan N; Clarke DK; Hendry RM; Eldridge JH; Udem SA; Kowalski J
    J Virol; 2006 May; 80(9):4447-57. PubMed ID: 16611905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunization with a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: long-term protection and effect of revaccination.
    Rooney JF; Wohlenberg C; Cremer KJ; Moss B; Notkins AL
    J Virol; 1988 May; 62(5):1530-4. PubMed ID: 2833606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Co-immunization with plasmids coding the full length and a soluble form of glycoprotein D of HSV-2 induces protective cellular and humoral immune response in mice.
    Fló J
    Vaccine; 2003 Mar; 21(11-12):1239-45. PubMed ID: 12559804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Murine Model of Maternal Immunization Demonstrates Protective Role for Antibodies That Mediate Antibody-Dependent Cellular Cytotoxicity in Protecting Neonates From Herpes Simplex Virus Type 1 and Type 2.
    Kao CM; Goymer J; Loh LN; Mahant A; Burn Aschner C; Herold BC
    J Infect Dis; 2020 Feb; 221(5):729-738. PubMed ID: 31599942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rectal immunization generates protective immunity in the female genital tract against herpes simplex virus type 2 infection: relative importance of myeloid differentiation factor 88.
    Tengvall S; O'Hagan D; Harandi AM
    Antiviral Res; 2008 Jun; 78(3):202-14. PubMed ID: 18276020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunological properties of a DNA plasmid encoding a chimeric protein of herpes simplex virus type 2 glycoprotein B and glycoprotein D.
    Domingo C; Gadea I; Pardeiro M; Castilla C; Fernández S; Fernández-Clua MA; De la Cruz Troca JJ; Punzón C; Soriano F; Fresno M; Tabarés E
    Vaccine; 2003 Sep; 21(25-26):3565-74. PubMed ID: 12922084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of DNA priming-protein boosting on enhancing humoral immunity and protecting mice against lethal HSV infections.
    Soleimanjahi H; Roostaee MH; Rasaee MJ; Mahboudi F; Kazemnejad A; Bamdad T; Zandi K
    FEMS Immunol Med Microbiol; 2006 Feb; 46(1):100-6. PubMed ID: 16420602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccination with the Secreted Glycoprotein G of Herpes Simplex Virus 2 Induces Protective Immunity after Genital Infection.
    Önnheim K; Ekblad M; Görander S; Bergström T; Liljeqvist JÅ
    Viruses; 2016 Apr; 8(4):110. PubMed ID: 27110813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaccination of mice with herpes simplex virus type 1 glycoprotein D DNA produces low levels of protection against lethal HSV-1 challenge.
    Ghiasi H; Cai S; Slanina S; Nesburn AB; Wechsler SL
    Antiviral Res; 1995 Oct; 28(2):147-57. PubMed ID: 8585768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High level expression and secretion of truncated forms of herpes simplex virus type 1 and type 2 glycoprotein D by the methylotrophic yeast Pichia pastoris.
    van Kooij A; Middel J; Jakab F; Elfferich P; Koedijk DG; Feijlbrief M; Scheffer AJ; Degener JE; The TH; Scheek RM; Welling GW; Welling-Wester S
    Protein Expr Purif; 2002 Aug; 25(3):400-8. PubMed ID: 12182819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Global sensing of the antigenic structure of herpes simplex virus gD using high-throughput array-based SPR imaging.
    Cairns TM; Ditto NT; Lou H; Brooks BD; Atanasiu D; Eisenberg RJ; Cohen GH
    PLoS Pathog; 2017 Jun; 13(6):e1006430. PubMed ID: 28614387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.